Intensive weekly chemotherapy good-prognosis patients small-cell lung cancer weekly intensive chemotherapy regimen patients small-cell lung cancer SCLC Forty-five patients disease LD extensive disease ED good prognostic features regimen cisplatin IV day IV days weekly ifosfamide IV day IV day total weeks Dose modifications hematologic criteria patients limited disease mediastinal radiotherapy Overall response chemotherapy complete response CR rate Forty-five patients limited disease LD overall response rate CR rate patients extensive disease ED overall response rate CR rate Median survival whole group weeks LD weeks ED weeks Hematologic toxicity predictable wide fluctuations WBC count conventional regimens quarter treatment courses leukopenia Dose reductions cases average dose intensity Nonhematologic toxicity mild nausea common weekly schedule chemotherapy active conventional chemotherapy randomized study 